NCT Number: NCT01809964
Clinical Trial to Evaluate ANT-1401 in Crow's Feet
The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Birmingham, Alabama, United States
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 30 - 60 years of age
- mild to moderate Crow's Feet wrinkles (IGA 1-2) at rest
- moderate to severe Crow's Feet (IGA 2-3) on contraction
- moderate to severe Crow's Feet (SSA 2-3) on contraction
- Have adequate vision to assess facial wrinkles in a mirror
Exclusion criteria
- botulinum toxin treatment in the prior 6 months
- history of periocular surgery, brow lift or related procedures
- soft tissue augmentation in the lateral canthal region in the prior 12 months
- dermabrasion or laser treatment in the periocular region in the last 6 months
- topical prescription-strength retinoids in the prior 3 months
- present or history of neuromuscular disease
- present or history of "dry eye"
- systemic aminoglycoside use in the week prior to treatment application
Treatment and study plan
Vehicle
BiologicalPrimary outcomes
-
Investigator's Global Assessment Scale
Time frame: Week 4
Secondary outcomes
-
Subject Self-Assessment
Time frame: Week 4
Sponsors and collaborators
Lead sponsor
Anterios Inc.
Industry
Registry information
Official study title
Clinical Trial to Evaluate ANT-1401 in Subjects With Lateral Canthal Lines
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Mar 13, 2013
- Registry last updated
- Jan 10, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Princess® RICH for the Correction of Fine Lines
NCT03923634
Lateral Canthal Lines, Perioral Rhytids
Graz, Austria
View Trial DetailsMT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
NCT04157686
Glabellar Lines, Lateral Canthal Lines
Scottsdale, Arizona, United States
View Trial DetailsMT10109L in the Treatment of Lateral Canthal Lines
NCT03785145
Lateral Canthal Lines
Glendale, Arizona, United States
View Trial DetailsMT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
NCT03732833
Glabellar Lines, Lateral Canthal Lines
Scottsdale, Arizona, United States
View Trial Details